Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Zydus Cadila launches remdesivir at Rs 2800 per 100 mg vial
To be sold under brand name Remdac, the API for the drug has been developed and manufactured at the company’s API manufacturing…
SeQuent Scientific to sell stake in Strides Pharma
Arun Kumar’s Family Office, part of the existing promoters of SeQuent Scientific to purchase 3.31 million shares for Rs 1,573…
Expert Committee discuss strategy for availability and delivery mechanism of COVID-19 vaccines
Experts also deliberated on creation of a digital infrastructure for inventory management and delivery mechanism of the vaccine…
Pharma units in Sikkim affected by COVID-19, production slashed by 25-30 per cent
Presently, the State has approximately 48 pharma units and around 10 pharma units have been declared as active containment zones…
Stanford study reveals immune-system deviations in severe COVID-19 cases
The study revealed, paradoxically, that the worse the case of COVID-19, the less effective certain cells of the innate immune…
Post-COVID, there will be a mix of various working models
Koki Sato, Country Head and GM, Takeda India talks about the company’s recent drug launch in India, its plans for the Indian…
Remdesivir shortage is India is easing: Cipla
The company has informed that it has started producing remdesivir at a plant in Goa in western India to ramp up production
American Gene Technologies gets US FDA nod for Phase 1 clinical trial of potential HIV cure
AGT’s Phase 1 trial will investigate the safety of AGT103-T, a single-dose, lentiviral vector-based gene therapy, and measure key…
Mission Atma Nirbhar in pharma
BR Sikri, Chairman, FOPE, highlights that the pharma sector is key to India’s economic progress and ensuring its self-reliance in…
Advent Life Sciences announces sale of KaNDy Therapeutics to Bayer
The sale is for $425 million upfront plus potential milestone payments of up to $425 million followed by further potential…